Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Maria Elisabetta Fratto"'
Autor:
Daniele Santini, Maria Elisabetta Fratto, Bruno Vincenzi, Silvia Angeletti, Giordano Dicuonzo, Gaia Schiavon, Giuseppe Tonini
Publikováno v:
Oncology Reviews, Vol 1, Iss 3, Pp 141-151 (2011)
Bisphosphonate therapy has become a standard of therapy for patients with malignant bone disease. In vivo pre-clinical data suggest that bisphosphonates may exert an antitumor effect and preliminary clinical data show promising activity on metastatic
Externí odkaz:
https://doaj.org/article/dd36869a3bfd49baafc85ccfd213ad39
Autor:
Matteo Zanuzzi, Pierluigi Russo, Maria Elisabetta Fratto, Angelica Carletto, Andrea Marcellusi, Tommaso Staniscia, Ferdinando Romano, Giampiero Favato
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 24(9)
Objective The main objective of this study was to evaluate the potential role of efficacy data and other information available at the time of price and reimbursement (P&R) decision-making process within the definition of oncology treatment costs in I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f881390d9c4d0d9cc19c6281d91771
https://pubmed.ncbi.nlm.nih.gov/34452706
https://pubmed.ncbi.nlm.nih.gov/34452706
Autor:
Marco Imperatori, Francesco Pantano, Maria Elisabetta Fratto, Giuseppe Tonini, Bruno Vincenzi, Daniele Santini
Publikováno v:
Expert Review of Anticancer Therapy. 11:921-930
Renal cell carcinoma represents approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. Many agents that target angiogenesis (e.g., sunitinib, sorafenib, bevacizumab and pazopanib) and mTOR-targeted therapy (e.g., tems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be08dba33eb6f2512b6f8e5ff18a8fd2
https://doi.org/10.1586/era.11.63
https://doi.org/10.1586/era.11.63
Autor:
Maria Elisabetta Fratto, Daniele Santini, Nicola Napoli, Giuseppe Tonini, M. Tantardini, Alberto Abbruzzese, Sara Galluzzo, Michele Caraglia, Bruno Vincenzi
Publikováno v:
Current Cancer Drug Targets. 9:834-842
This system constituted of the Receptor Activator of nuclear Factor-kB Ligand (RANKL), the Receptor Activator of Nuclear Factor-kB (RANK) and by the decoy Receptor Osteoprotegerin (OPG) plays a central role in bone resorption. Denosumab (AMG 162) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407011c3d354e6886546be8d39ef26a7
https://doi.org/10.2174/156800909789760375
https://doi.org/10.2174/156800909789760375
Autor:
Maria Elisabetta Fratto, Daniele Santini, Giuseppe Tonini, Silvia Angeletti, Gaia Schiavon, Giordano Dicuonzo, Sara Galluzzo, Bruno Vincenzi
Publikováno v:
Oncology Reviews. 1:141-151
Bisphosphonate therapy has become a standard of therapy for patients with malignant bone disease. In vivo pre-clinical data suggest that bisphosphonates may exert an antitumor effect and preliminary clinical data show promising activity on metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e701bbaf312f15c37d6518f6514d53
https://doi.org/10.1007/s12156-007-0017-1
https://doi.org/10.1007/s12156-007-0017-1
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 192
Skeletal metastases affect a large percentage of the cancer population and contribute to a marked decrease in their quality of life and survival, in particular in elderly population. A future end-point of bone-protecting therapy is the demonstration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26f45926a220eae0471d7595989e412a
https://pubmed.ncbi.nlm.nih.gov/22307375
https://pubmed.ncbi.nlm.nih.gov/22307375
Publikováno v:
Prevention of Bone Metastases ISBN: 9783642218910
Skeletal metastases affect a large percentage of the cancer population and contribute to a marked decrease in their quality of life and survival, in particular in elderly population. A future end-point of bone-protecting therapy is the demonstration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::431af0f325b06bae3d01df919a1d0063
https://doi.org/10.1007/978-3-642-21892-7_8
https://doi.org/10.1007/978-3-642-21892-7_8
Autor:
Bruno Vincenzi, Evaristo Maiello, Cristina Masini, Olga Venditti, Raffaele Addeo, Alfredo Falcone, Vincenzo Catalano, Vladimir Virzì, Cinzia Ortega, R. Giannicola, N. Calipari, Toni Ibrahim, Giuseppe Tonini, Paolo Giordani, Calogero Mazzara, Azzurra Ottone, Fausto Petrelli, Stefano Cascinu, Nicola Silvestris, Federica Bertolini, Daniele Santini, Lisa Salvatore, Sandro Barni, Tiziana Latiano, Maria Elisabetta Fratto, Marco Tampellini, Cinzia Caroti, Rossana Berardi, Massimo Aglietta, Giuseppe Badalamenti, Davide Ottaviani, Francesco Fabbri
Publikováno v:
Università di Pisa-IRIS
Background Data are limited regarding bone metastases from colorectal cancer (CRC). The objective of this study was to survey the natural history of bone metastasis in CRC. Patients and methods This retrospective, multicenter, observational study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17964d6db18429e47c5a0bae81b08d21
https://hdl.handle.net/11380/1079252
https://hdl.handle.net/11380/1079252
Autor:
Maria Elisabetta Fratto, Nicola Silvestris, Alice Zoccoli, Amalia Azzariti, Bruno Vincenzi, Stefania Tommasi, Daniele Santini, Giuseppe Tonini, Sara Galluzzo, Giuseppe Colucci, Evaristo Maiello
Publikováno v:
Scopus-Elsevier
The key role of epidermal growth factor receptor(EGFR) in tumorigenesis has been demonstrated in several cancer types, so recent clinical trials have investigated their activity/efficacy in different settings. Two different types of EGFR-targeted age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1e609f4e4af2871c6bd4b515766adc
http://hdl.handle.net/11573/1642465
http://hdl.handle.net/11573/1642465
Autor:
Evaristo Maiello, Alice Zoccoli, Antonio Russo, Elisabetta Riva, Daniele Santini, Nicola Silvestris, Maria Elisabetta Fratto, Sergio Rizzo, Giuseppe Colucci, Lucia Lombardi, Bruno Vincenzi, Sara Galluzzo, C. Gucciardino, Francesco Pantano, Giuseppe Tonini
Publikováno v:
Cancer treatment reviews. 36
Bone metastases have a major impact on morbidity and on mortality in cancer patients. Despite its clinical relevance, metastasis remains the most poorly elucidated aspect of carcinogenesis. The biological mechanisms leading to bone metastasis establi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f210a0f74a8aeea2414d7c4e494696c3
https://pubmed.ncbi.nlm.nih.gov/21129612
https://pubmed.ncbi.nlm.nih.gov/21129612